AbCellera Reports Q2 2025 Business Results & Initiation of a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms ...

Lilly’s orforglipron cut body weight as expected in the Phase III ATTAIN-1 trial, but to a lesser extent than rival Novo ...

The Albany International Airport has completed the first phase of its Concourse A Rehabilitation Project. Phase one included ...

It looks likely we'll see oral GLP-1 drugs on the market by next year, with pharmaceutical company Eli Lilly reporting ...

VALORANT’s Esports Product Manager has revealed a list of tournaments which will offer direct qualification to Project ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The Pension Fund Regulatory and Development Authority has published 40 vacancies for the recruitment of Officer Grade ‘A’ ...

The African Development Bank (AFDB) said Phase 2 of its Special Agro-Industrial Processing Zones, which will cover the remaining 28 States, is scheduled to take off from September 2025.

On Thursday, Eli Lilly and Co.’s (NYSE:LLY) weight loss rival Novo Nordisk A/S (NYSE:NVO), along with smaller firms, Terns ...

Now, new clinical trial results suggest that an oral form of this medication may be coming soon—and the results so far are ...

The summer heat may be the focus for many in Holland this August, but anticipation is growing for the more than $11 million ...

More than one million gallons of hazardous pollutants have been removed from the USS Yorktown as a years-long environmental ...